| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |